Blog
RSS FeedPosted by Michael Wonder on 07 Feb 2018
Canadian generic drug prices higher than international levels in recent years
6 February 2018 - The Patented Medicine Prices Review Board releases its latest report on generic drug pricing in Canada. ...
Posted by Michael Wonder on 07 Feb 2018
AbbVie receives a positive recommendation from the CADTH Canadian Drug Expert Committee for Maviret – an oral therapy for the treatment of patients with hepatitis C
6 February 2018 - Maviret previously received a Notice of Compliance from Health Canada on 16 August 2017. ...
Posted by Michael Wonder on 06 Feb 2018
Quebec adds Erelzi (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
5 February 2018 - Erelzi has been added to the Quebec Drug Insurance Plan based on specific criteria for the treatment ...
Posted by Michael Wonder on 05 Feb 2018
Acerus Pharma’s Natesto to be listed for public reimbursement in Quebec
1 February 2018 - Acerus Pharmaceuticals Corporation today announced that it has received notice from Quebec’s National Institute for Excellence ...
Posted by Michael Wonder on 04 Feb 2018
The real story behind the sudden drop in Canada's drug prices
3 February 2018 - And is Ontario offering a college diploma in 'pseudoscience?' ...
Posted by Michael Wonder on 29 Jan 2018
A joint statement from the pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association
29 January 2018 - On behalf of participating federal, provincial, and territorial public drug plans, the pan-Canadian Pharmaceutical Alliance (pCPA), with ...
Posted by Michael Wonder on 21 Jan 2018
At $262.40 per pill, the cancer drug that could save her life isn’t covered in B.C.
19 January 2018 - Karen McLaren of Langley has stage four breast cancer, and has been prescribed a drug that could ...
Posted by Michael Wonder on 16 Jan 2018
How Ottawa's using a fake drug crisis to force through damaging pharmaceutical policy
16 January 2018 - There is no affordability crisis to justify expanding drug price regulation, or a new national government-run pharmacare ...
Posted by Michael Wonder on 10 Jan 2018
Ontario has added Erelzi (etanercept) to public drug plan for the treatment of multiple inflammatory diseases
9 January 2018 - Erelzi has been added to public drug plan based on specific criteria in Ontario for the treatment ...
Posted by Michael Wonder on 29 Dec 2017
Montreal woman with ALS fights for Canadian access to new drugs
28 December 2017 - 'Please help us get access. ALS is a fatal disease and it goes fast,' Montrealer Nancy Roch ...
Posted by Michael Wonder on 18 Dec 2017
Melissa’s battle hurts
17 December 2017 - Residents urged to pressure government to help Vernon woman gain access to life-saving medication. ...
Posted by Michael Wonder on 13 Dec 2017
Edmonton woman begs Alberta to cover life-changing $250K cystic fibrosis drug
12 December 2017 - At 25 years old, cystic fibrosis patient Katrina Secord says her fate is in the hands ...
Posted by Michael Wonder on 13 Dec 2017
Update on revised process for biosimilars
12 December 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the submission and ...
Posted by Michael Wonder on 11 Dec 2017
Call for feedback: medicine for the management of rheumatoid arthritis
9 December 2017 - A draft report on medicine for the management of rheumatoid arthritis is now available for feedback from ...
Posted by Michael Wonder on 05 Dec 2017
Canada's regulator of patented drug prices is rigging data, and risking our health
5 December 2017 - The patent medicine pricing board is making a blatant attempt to bias the data. ...